Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73

Xenopus p53 has biological and biochemical properties similar to those of human p53, except for optimal temperature. The frog protein is fully active at 30 °C and inactive at 37 °C, leading to a temperature-sensitive behavior similar to that of the human mutant p53Ala 143 and the murine mutant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2003-03, Vol.278 (12), p.10546
Hauptverfasser: Karim Bensaad, Morgane Le Bras, Keziban Unsal, Sabrina Strano, Giovanni Blandino, Osamu Tominaga, Dany Rouillard, Thierry Soussi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Xenopus p53 has biological and biochemical properties similar to those of human p53, except for optimal temperature. The frog protein is fully active at 30 °C and inactive at 37 °C, leading to a temperature-sensitive behavior similar to that of the human mutant p53Ala 143 and the murine mutant p53Val 135 . Using hybrid proteins between human and Xenopus expressed from artificial p53 minigenes, we have been able to demonstrate that change of conformation of the DNA-binding domain is the major determinant of this heat sensitivity. It has been reported that some human tumor-derived p53 mutants can engage in a physical association with p73, thus inhibiting its transactivating properties. The mechanism of this association remains to be elucidated. The nature of the mutant p53 that can engage in this association also remains controversial. Using the unique opportunity of the temperature sensitivity of Xenopus p53, we demonstrate that binding of and interference with p73 require a change of conformation in the p53 protein. This interaction occurs through the DNA-binding domain of p53 only when it is in a denatured state. These results reinforce the notion that mutant p53 with a conformational change can act as a down-regulator of the p73 pathway in human cancer and could confer a selective advantage to the tumor.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M208233200